174 related articles for article (PubMed ID: 10647500)
21. Antioxidants specifically inhibit cisplatin cytotoxicity of human malignant glioma cells.
Roller A; Weller M
Anticancer Res; 1998; 18(6A):4493-7. PubMed ID: 9891515
[TBL] [Abstract][Full Text] [Related]
22. G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.
Li L; Khan MN; Li Q; Chen X; Wei J; Wang B; Cheng JW; Gordon JR; Li F
Oncol Rep; 2015 Feb; 33(2):751-7. PubMed ID: 25504010
[TBL] [Abstract][Full Text] [Related]
23. Antitumor, nephrotoxic and clastogenic effect of cis-DDP with DDTC or NAC.
Konstantinov S; Topashka-Ancheva M; Karaivanova M; Zoneva G; Galova I
Neoplasma; 1994; 41(5):253-8. PubMed ID: 7854494
[TBL] [Abstract][Full Text] [Related]
24. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
Holzer AK; Manorek GH; Howell SB
Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
[TBL] [Abstract][Full Text] [Related]
25. Mouse monocytes (RAW CELLS) and the handling of cysteine and homocysteine S-conjugates of inorganic mercury and methylmercury.
Zalups RK; Koropatnick J; Joshee L
J Toxicol Environ Health A; 2007 May; 70(10):799-809. PubMed ID: 17454556
[TBL] [Abstract][Full Text] [Related]
26. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity.
Yang C; Kaushal V; Haun RS; Seth R; Shah SV; Kaushal GP
Cell Death Differ; 2008 Mar; 15(3):530-44. PubMed ID: 18064040
[TBL] [Abstract][Full Text] [Related]
28. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
Waud WR
Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093
[TBL] [Abstract][Full Text] [Related]
29. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
Chen G; Zeller WJ; Todorov DK
Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
[TBL] [Abstract][Full Text] [Related]
30. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro.
Melvik JE; Pettersen EO
Radiat Res; 1988 Jun; 114(3):489-99. PubMed ID: 3375438
[TBL] [Abstract][Full Text] [Related]
31. Specific amino acids moderate the effects on Ni2+ on the testosterone production of mouse leydig cells in vitro.
Forgács Z; Némethy Z; Révész C; Lázár P
J Toxicol Environ Health A; 2001 Mar; 62(5):349-58. PubMed ID: 11261897
[TBL] [Abstract][Full Text] [Related]
32. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
33. Modulation of cadmium chloride toxicity by sulphur amino acids in hepatoma cells.
Fotakis G; Timbrell JA
Toxicol In Vitro; 2006 Aug; 20(5):641-8. PubMed ID: 16442773
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of p38-MAPK potentiates cisplatin-induced apoptosis via GSH depletion and increases intracellular drug accumulation in growth-arrested kidney tubular epithelial cells.
Rodríguez-García ME; Quiroga AG; Castro J; Ortiz A; Aller P; Mata F
Toxicol Sci; 2009 Oct; 111(2):413-23. PubMed ID: 19578154
[TBL] [Abstract][Full Text] [Related]
35. Use of cellular electrical impedance sensing to assess in vitro cytotoxicity of anticancer drugs in a human kidney cell nephrotoxicity model.
Xie F; Xu Y; Wang L; Mitchelson K; Xing W; Cheng J
Analyst; 2012 Mar; 137(6):1343-50. PubMed ID: 22214987
[TBL] [Abstract][Full Text] [Related]
36. In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenografts.
Jamshidipour R; Pinho EB; Howell SB
Anticancer Res; 1994; 14(6B):2611-6. PubMed ID: 7872689
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of sodium selenite minimizes cisplatin toxicity on proximal tubules of rats.
Camargo SM; Francescato HD; Lavrador MA; Bianchi ML
Biol Trace Elem Res; 2001 Dec; 83(3):251-62. PubMed ID: 11794517
[TBL] [Abstract][Full Text] [Related]
38. Protective role of metallothionein in renal toxicity of cisplatinum.
Satoh M; Aoki Y; Tohyama C
Cancer Chemother Pharmacol; 1997; 40(4):358-62. PubMed ID: 9225956
[TBL] [Abstract][Full Text] [Related]
39. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
Bodenner DL; Dedon PC; Keng PC; Borch RF
Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800
[TBL] [Abstract][Full Text] [Related]
40. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats.
Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L
Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
